Law360, New York (October 11, 2012, 8:22 PM ET) -- As the number of meningitis outbreak fatalities rose to 14 on Thursday, one federal lawmaker sought a criminal probe into the compounding pharmacy behind the outbreak, while a U.S. Food and Drug Administration official called for an overhaul of the regulation of compounded drugs.
The U.S. Centers for Disease Control and Prevention issued its first health alert in connection with the outbreak on Oct. 4, when 35 people in six states were known to have contracted fungal meningitis after receiving injections of a steroid manufactured by...
Meningitis Outbreak Spurs Push For Compounder Crackdown
To view the full article, take a free trial now.
